Biohaven (BHVN) News Today → DON’T buy gold until you read this (From Sasco Gold LLC) (Ad) Free BHVN Stock Alerts $35.09 +1.45 (+4.31%) (As of 06/10/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 10 at 6:42 PM | marketbeat.com1,075,000 Shares in Biohaven Ltd. (NYSE:BHVN) Bought by Bellevue Group AGBellevue Group AG bought a new position in shares of Biohaven Ltd. (NYSE:BHVN - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 1,075,000 shares of the company's stock, valued at approximatelyJune 10 at 1:20 AM | marketbeat.comBiohaven Ltd. (NYSE:BHVN) Given Average Recommendation of "Buy" by BrokeragesShares of Biohaven Ltd. (NYSE:BHVN - Get Free Report) have been assigned an average rating of "Buy" from the eight ratings firms that are covering the company, Marketbeat reports. Eight research analysts have rated the stock with a buy recommendation. The average 12-month price objective among broJune 9 at 4:02 AM | americanbankingnews.comBiohaven (NYSE:BHVN) Shares Up 3.8%June 7 at 1:20 PM | marketbeat.comBiohaven (NYSE:BHVN) Trading Up 3.8%Biohaven (NYSE:BHVN) Trading Up 3.8%June 5, 2024 | marketbeat.comArmistice Capital LLC Sells 536,000 Shares of Biohaven Ltd. (NYSE:BHVN)Armistice Capital LLC lessened its position in Biohaven Ltd. (NYSE:BHVN - Free Report) by 26.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,500,000 shares of the company's stock after selling 536,000 shares during the quaJune 4, 2024 | marketbeat.comRafferty Asset Management LLC Trims Position in Biohaven Ltd. (NYSE:BHVN)Rafferty Asset Management LLC cut its holdings in shares of Biohaven Ltd. (NYSE:BHVN - Free Report) by 20.8% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 271,577 shares of the company's stock after selling 71,284 shares during the period. RaffertJune 2, 2024 | americanbankingnews.comJohn W. Childs Acquires 28,000 Shares of Biohaven Ltd. (NYSE:BHVN) StockJune 2, 2024 | americanbankingnews.comBiohaven (NYSE:BHVN) Shares Gap Up on Insider Buying ActivityJune 1, 2024 | insidertrades.comBiohaven Ltd. (NYSE:BHVN) Director John W. Childs Purchases 28,000 SharesMay 31, 2024 | marketbeat.comBiohaven (NYSE:BHVN) Shares Gap Up Following Insider Buying ActivityBiohaven (NYSE:BHVN) Shares Gap Up Following Insider Buying ActivityMay 31, 2024 | americanbankingnews.comBiohaven (NYSE:BHVN) Earns "Buy" Rating from HC WainwrightMay 31, 2024 | americanbankingnews.comBiohaven (NYSE:BHVN) Earns Overweight Rating from Cantor FitzgeraldMay 30, 2024 | marketbeat.comBiohaven (NYSE:BHVN) Given "Buy" Rating at HC WainwrightHC Wainwright reissued a "buy" rating and issued a $59.00 price objective on shares of Biohaven in a research note on Thursday.May 29, 2024 | markets.businessinsider.comBiohaven Reports Positive Data From Phase 1 Study Of BHV-1300May 29, 2024 | msn.comWhat's Going On With Biohaven Stock Wednesday?May 29, 2024 | marketbeat.comBiohaven (NYSE:BHVN) Shares Gap Down to $37.94Biohaven (NYSE:BHVN) Shares Gap Down to $37.94May 29, 2024 | msn.comBiohaven stock falls 30% premarket amid drug updatesMay 29, 2024 | prnewswire.comBiohaven Showcases Broad Innovative Portfolio and Pipeline Updates Across Multiple Therapeutic Areas including Immunology, Neuroscience, Metabolic Disorders and Oncology at Annual Investor R&D DayMay 29, 2024 | prnewswire.comBiohaven Doses First Patient with its Novel Trop-2 Directed Antibody Drug Conjugate (ADC) BHV-1510 in Advanced or Metastatic Epithelial TumorsMay 28, 2024 | marketbeat.comStifel Financial Corp Boosts Stake in Biohaven Ltd. (NYSE:BHVN)Stifel Financial Corp lifted its stake in shares of Biohaven Ltd. (NYSE:BHVN - Free Report) by 7.9% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 6,225,811 shares of the company's stock after buying an additional 456,062 sharMay 28, 2024 | marketbeat.comBiohaven (NYSE:BHVN) Stock Price Up 4.2%Biohaven (NYSE:BHVN) Trading Up 4.2%May 25, 2024 | marketbeat.comCharles Schwab Investment Management Inc. Grows Position in Biohaven Ltd. (NYSE:BHVN)Charles Schwab Investment Management Inc. boosted its stake in Biohaven Ltd. (NYSE:BHVN - Free Report) by 20.1% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 518,904 shares of the company's stock after buying an additional 86,May 20, 2024 | marketbeat.comBiohaven (NYSE:BHVN) Shares Up 6.4%Biohaven (NYSE:BHVN) Trading 6.4% HigherMay 18, 2024 | seekingalpha.comBiohaven: Promising Pipeline With Troriluzole, Taldefgrobep Alfa, And BHV-7000 Leading The ChargeMay 16, 2024 | marketbeat.comBiohaven (NYSE:BHVN) Shares Gap Down to $37.08Biohaven (NYSE:BHVN) Shares Gap Down to $37.08May 16, 2024 | marketbeat.comBiohaven Ltd. (NYSE:BHVN) Short Interest UpdateBiohaven Ltd. (NYSE:BHVN - Get Free Report) was the recipient of a large increase in short interest in the month of April. As of April 30th, there was short interest totalling 9,630,000 shares, an increase of 8.1% from the April 15th total of 8,910,000 shares. Based on an average trading volume of 1,300,000 shares, the days-to-cover ratio is currently 7.4 days.May 16, 2024 | marketbeat.comBiohaven Ltd. (NYSE:BHVN) Given Average Rating of "Buy" by AnalystsBiohaven Ltd. (NYSE:BHVN - Get Free Report) has been given an average rating of "Buy" by the eight brokerages that are currently covering the company, MarketBeat Ratings reports. Eight analysts have rated the stock with a buy recommendation. The average 12 month target price among brokers that havMay 15, 2024 | marketbeat.comNicholas Investment Partners LP Has $5.12 Million Stock Position in Biohaven Ltd. (NYSE:BHVN)Nicholas Investment Partners LP reduced its position in Biohaven Ltd. (NYSE:BHVN - Free Report) by 79.8% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 119,512 shares of the company's stock after selling 4May 15, 2024 | finance.yahoo.comDirector Gregory Bailey Acquires 15,000 Shares of Biohaven Ltd (BHVN)May 15, 2024 | marketbeat.comFY2024 Earnings Estimate for Biohaven Ltd. (NYSE:BHVN) Issued By Cantor FitzgeraldBiohaven Ltd. (NYSE:BHVN - Free Report) - Investment analysts at Cantor Fitzgerald dropped their FY2024 earnings per share estimates for Biohaven in a report issued on Monday, May 13th. Cantor Fitzgerald analyst C. Duncan now anticipates that the company will post earnings of ($7.46) per share foMay 15, 2024 | insidertrades.comInsider Buying: Biohaven Ltd. (NYSE:BHVN) Director Buys 28,500 Shares of StockMay 14, 2024 | markets.businessinsider.comBuy Rating Affirmed on Biohaven Ltd. Amidst Pipeline Potential and Upcoming DevelopmentsMay 14, 2024 | marketbeat.comBiohaven (NYSE:BHVN) Trading 9.4% Higher on Insider Buying ActivityBiohaven (NYSE:BHVN) Trading Up 9.4% on Insider Buying ActivityMay 14, 2024 | marketbeat.comInsider Buying: Biohaven Ltd. (NYSE:BHVN) Director Acquires 28,500 Shares of StockBiohaven Ltd. (NYSE:BHVN - Get Free Report) Director John W. Childs bought 28,500 shares of Biohaven stock in a transaction on Monday, May 13th. The shares were purchased at an average cost of $35.17 per share, for a total transaction of $1,002,345.00. Following the acquisition, the director now owns 2,283,341 shares in the company, valued at $80,305,102.97. The purchase was disclosed in a filing with the SEC, which is available at the SEC website.May 13, 2024 | marketbeat.comBiohaven (NYSE:BHVN) Trading Down 2.2% Following Analyst DowngradeBiohaven (NYSE:BHVN) Trading Down 2.2% Following Analyst DowngradeMay 13, 2024 | marketbeat.comBiohaven (NYSE:BHVN) PT Lowered to $59.00 at HC WainwrightHC Wainwright cut their target price on shares of Biohaven from $63.00 to $59.00 and set a "buy" rating on the stock in a research note on Monday.May 10, 2024 | finanznachrichten.deBiohaven Ltd.: Biohaven Reports First Quarter 2024 Financial Results and Recent Business DevelopmentsMay 10, 2024 | investorplace.comBHVN Stock Earnings: Biohaven Misses EPS for Q1 2024May 9, 2024 | msn.comBiohaven reports Q1 resultsMay 9, 2024 | prnewswire.comBiohaven Reports First Quarter 2024 Financial Results and Recent Business DevelopmentsMay 2, 2024 | finance.yahoo.comBiohaven Ltd. (BHVN)May 1, 2024 | investorplace.comShhh! 3 Secret Biotech Stocks Flying Below Wall Street's RadarApril 28, 2024 | 247wallst.comThese Biotechs and IPOs Inspire Big Insider BuyingApril 26, 2024 | finance.yahoo.comIndependent Director of Biohaven John Childs Buys 3.2% More SharesApril 26, 2024 | marketbeat.comBiohaven Ltd. (NYSE:BHVN) Expected to Post FY2024 Earnings of ($6.13) Per ShareBiohaven Ltd. (NYSE:BHVN - Free Report) - Stock analysts at Cantor Fitzgerald lifted their FY2024 EPS estimates for shares of Biohaven in a report issued on Wednesday, April 24th. Cantor Fitzgerald analyst C. Duncan now expects that the company will post earnings of ($6.13) per share for the yearApril 26, 2024 | marketbeat.comJennison Associates LLC Takes $11.40 Million Position in Biohaven Ltd. (NYSE:BHVN)Jennison Associates LLC bought a new position in Biohaven Ltd. (NYSE:BHVN - Free Report) during the fourth quarter, according to the company in its most recent filing with the SEC. The firm bought 266,391 shares of the company's stock, valued at approximately $11,402,000. Jennison Associates LLC owApril 26, 2024 | msn.com3 Biotech Stocks to Buy on the Dip: April 2024April 26, 2024 | insidertrades.comBiohaven Ltd. (NYSE:BHVN) Director Acquires $999,207.54 in StockApril 25, 2024 | markets.businessinsider.comRBC Capital Keeps Their Buy Rating on Biohaven Ltd. (BHVN)April 25, 2024 | finance.yahoo.comDirector Gregory Bailey Acquires 25,503 Shares of Biohaven Ltd (BHVN) Get Biohaven News Delivered to You Automatically Sign up to receive the latest news and ratings for BHVN and its competitors with MarketBeat's FREE daily newsletter. Email Address The #1 Crypto That You Don’t Own… Yet (Ad)There’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay attention to above all others: Venture capital firms. You want to follow venture capital money into cryptocurrencies before anyone gets word of what’s happening. Click here for all the details… BHVN Media Mentions By Week BHVN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BHVN News Sentiment▼1.060.75▲Average Medical News Sentiment BHVN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BHVN Articles This Week▼64▲BHVN Articles Average Week Get Biohaven News Delivered to You Automatically Sign up to receive the latest news and ratings for BHVN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Sarepta Therapeutics News Catalent News Elanco Animal Health News Insmed News Roivant Sciences News Legend Biotech News Ascendis Pharma A/S News Cerevel Therapeutics News Intra-Cellular Therapies News Jazz Pharmaceuticals News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:BHVN) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredMoonshot Coins for the Current Crypto RunDid you see bitcoin crossed $70k again? Don't miss the next bull run. Because while Bitcoin and Ethereum s...Crypto 101 Media | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredMissed NVDA? Buy this AI stock NOWAfter Nvidia's record-breaking earnings surge, Wall Street is now selling the stock at the fastest pace in sev...Chaikin Analytics | Sponsored